Sanofi-Aventis Administrative Office
About Sanofi-Aventis Administrative Office
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sanofi
15
Clinical Trials at Sanofi-Aventis Administrative Office
During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
2001-04-01
2014-12-01
Completed
3,222
A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation
2005-06-01
2008-03-01
Completed
4,628
Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease
2003-07-01
2006-04-01
Completed
564
Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes
2005-12-01
2009-04-01
Terminated
18,695
Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder
2007-01-01
2008-02-01
Completed
510
Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients
2007-06-01
2010-08-01
Completed
330
Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
2007-06-01
2008-10-01
Completed
504
Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
2007-07-01
2010-01-01
Completed
1,617
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office"
#1 collaborator was "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Sanofi-Aventis Administrative Office
According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are
"Atrial Fibrillation" (2 trials), "Breast Neoplasms" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Hypertension" (2 trials) and "Acute Illness" (1 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.
Clinical Trials Intervention Types at Sanofi-Aventis Administrative Office
Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (15 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Lixisenatide (AVE0010)" (2 trials), "Pen auto-injector" (2 trials), "dronedarone (SR33589)" (2 trials) and "placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Sanofi-Aventis Administrative Office
The vast majority of trials in "Sanofi-Aventis Administrative Office" are
13 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Sanofi-Aventis Administrative Office
Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Sanofi-Aventis Administrative Office,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".